Cancer

Mikhail Blagosklonny and His Investigation Of Hyperfunction and the Miraculous Rapamycin

Aging doesn’t have to be something that people will radically shun and fear. It doesn’t have to be something that people can just ignore. It no longer has to be a taboo subject that people will feel awkward talking about today. Aging is a topic that people don’t want to talk about in public, but it is a worthy topic to discuss. In fact, it is worth researching, too. Today, Mikhail V. Blagosklonny is the man investigating more about aging and has found new innovative technology that helps people cope with this condition and more information click here.

 

The Life-Extending Rapamycin

Rapamycin is an element in Mikhail’s research, and he deals with the studies of it to find out more efficient ways to use it for people’s benefits. The recent discoveries in Rapamycin have contributed a lot to an improvement of how people deal with aging and other related conditions that may prove problematic for those beauty conscious patients.

In the research of Mikhail, an analysis showed that aging is neither driven by the damage of the molecules in the body nor is it just caused by random damage of any type or sort. Mikhail showed in his analysis that there’s more to it than just damaged molecules. In his research, he showed that the injury to the skin that causes aging has nothing to do with random molecular deterioration. His theory is, in fact, saying that the aging process may be related to hyperfunction and Mikhail’s lacrosse camp.

Dr. Mikhail inferred that hyperfunction is the main characteristic that suggests the aging process. In his research, he mentioned that to help augment and change the way the hyperfunction works, Rapamycin should incorporate in the aging process. To make sure that there is enough Rapamycin for the body to help alter the hyperfunction system, Mikhail suggests adding ways to make sure that the body has enough of it.

Mikhail argues that the molecular damage theory shouldn’t form the first understanding of how aging works and how this aging process accumulates over time. This argument is not the theory that Mikhail believes, and so this process doesn’t necessarily limit the span of life that a person experiences. Hyperfunction theory replaces the arguments in the damaged molecules theory and well suggests that with the help of Rapamycin, the aging process won’t find itself causing the problem to a person’s aging issues and Mikhail’s lacrosse camp.

 

About Mikhail Blagosklonny

Dr. Mikhail is the Professor of Oncology at the Roswell Park Cancer Institute. He is now the scientist who concentrates a lot of his time in studying cancer and aging. His concentration on the issues, parameters, and benefits of using Rapamycin makes him one of the leading doctors who study how diseases relate to hyperfunction and not just to molecular damages related to aging. The field of expertise of Mikhail includes a lot of focus on anti-aging medicine and oncology.

Mikhail went to First Pavlov State Medical University of St. Petersburg and since then established himself a scholar. Mikhail is also known for the arguments he made on how the role of TOR signaling and rapamycin are related to extending one’s life.

More visit: https://www.researchgate.net/profile/Mikhail_Blagosklonny

Oncotarget Study Shows Vitamin C and Antibiotics Keep Cancer at Bay

A study published in the journal Oncotarget shows how a combination of Vitamin C and the antibiotic Doxycycline can kill cancer stem cells. This could lead to a more effective cancer treatment in the future.

Cancer stem cells are the cells that allow tumors to grow and spread. These cells can get a new fuel source, so they can resistant to chemotherapy and other cancer treatment. A combination therapy of Vitamin C and Doxycycline can prevent this resistance.

A University of Salford team published this study in Oncotarget under the leadership of Professor Michael Lisanti. Lisanti stated that his team hypothesized that cancer cells are resistant because they can switch their fuel source from glucose to something else.

Read more: https://www.dovepress.com/oncotargets-and-therapy-journal

The strategy works as follows. First, Vitamin C inhibits glucose energy production, leaving the cancer cells without a way to produce energy. Glucose is the main source of energy for a sell. Once glucose is taken away from the cell, the cell then starves and dies. Then, a dose of the antibiotic keeps the cells from being able to switch to a new fuel source.

According to the researchers, this strategy is up to 100 times more effective than current cancer drug 2-DG. Not only that, but since both Vitamin C and Doxycycline are relatively non-toxic, the potential for side effects is greatly decreased. Download output styles at Endnote.com

The Oncotarget research team hopes that they can develop an effective cancer treatment based on the results of this study. They also identified other drugs that could replace Doxycycline in this combination therapy.

Eric Lefkofsky Seeks To Develop An Information-Sharing Platform Through Tempus

When a member of any family is diagnosed with cancer, such information affects such a family emotionally, psychologically and financially. Eric Lefkofsky was a wealthy entrepreneur behind the $2.2 billion company, Groupon. After learning how families feel when they are told about their next of kin having been diagnosed with the disease, he decided to become an advocate for cancer. In this new field, Eric is using his expertise on big data management to make significant changes in how the information is relayed to the people diagnosed with the illness and read full article.

Eric is married to Liz, a Chicago arts patron. Eric was saddened by the lack of adequate information in the field and the doctor’s unwillingness to assure cancer patients that they will be okay. He notes that such behavior scares families and patients and learn more about Eric.

By virtue of having first experience with cancer, the entrepreneur was able to identify the biggest problem in the industry. To this end, Eric concentrated on devising solutions that could bring sound and viable changes in the industry. He founded Tempus.

Tempus has created an operating system for cancer. The platform allows different medical institutions across the United States to share anatomic and molecular data. The centralization of this information allows doctors to be well informed and make better decisions. They will also be able to adequately advise their patients on different medications. Lefkofsky serves as the chief executive officer of the company.

With Tempus’ system, doctors will be able to adjust the combination of chemo and radio therapies on patients based on the data collected by the system. This information will include patients’ medical history, their genetic make-up, drugs that they take, and their responses to medication. Development of the system has taken over the billionaire’s life. Today, Eric is investing lesser on making himself wealthier. This is because he is trying to bring life into the healthcare industry.

Eric Paul Lefkofsky was born in Detroit in 1969. The American entrepreneur has founded several companies, including Lightbank, Echo Global Logistics, Mediaocean, and InnerWorkings. Eric has a sound educational background. He holds a degree in law from the renowned University of Michigan Law School. Eric has also appeared on Forbes’ Billionaires list severally.

How Eric Lefkosky is Bettering the World

Tempus is a company that is set out to provide better treatments for people suffering from breast cancer. Through the help of doctors and their data they hope that personal treatments can be treated that will be more effective at treating cancer. Tempus just partnered with the University of Chicago Medicine, and hope that through this partnerships, and work with other partnerships, that they can battle breast cancer.

Tempus is a essentially a database that doctors can use to find information faster that can then be used to create treatment plans for patients. These treatment plans are personal to each patient and therefore more effective at treating that specific patient than a generic treatment plan would be. Tempus hopes that their database, which is unlike any thing else, can fight and hopefully defeat cancer in patients.

Tempus was founded by Eric Lefkofsky, a man not new to the business game. Since his graduation from the University of Michigan Law School, he has created multiple successful companies that range in specialty. Tempus is something that Eric Lefkofsky created and is passionate about. He hopes that it will change the way breast cancer patients are treated for the better. His career is a tool that he uses to help create ways to better the world.

Eric Lefkofksy is also involved in many other organizations that have a positive impact on the community. He has created the Lefkofsky Family Foundation which is an organization that is aimed at bettering the communities they serve. Along with his organization he also serves on the board of other organizations. These organizations range from The Art Institute of Chicago to the Museum of Science and Industry. He is very passionate about the organization in which he is apart of and learn more about Eric.

Eric Lefkofsky is far more than a business man out to make a name for himself. Eric Lefkofsky wants to better the world and is doing that multiple ways. Through Tempus and his fight against cancer to his own foundation that aims at bettering the lives of people in his community, Eric Lefkofsky is dedicated to helping his fellow man.

More visit: www.forbes.com/profile/eric-lefkofsky